Low Estradiol with Normal FSH and Amenorrhea: Functional Hypothalamic Amenorrhea
This presentation is most consistent with functional hypothalamic amenorrhea (FHA), and the primary treatment is correcting the underlying energy imbalance through increased caloric intake, reduced exercise, and/or weight gain—not hormonal therapy. 1
Diagnostic Approach
The hormonal pattern you describe—low estradiol (<50 pg/mL) with normal FSH levels (often higher than LH)—is the hallmark of FHA 1. This differs critically from:
- Ovarian insufficiency: Would show elevated FSH and LH with low estradiol
- Organic hypogonadotropic hypogonadism: Would show very low or undetectable FSH and LH (not normal levels)
- Midcycle surge: Would show high FSH/LH with estradiol >150 pg/mL
Required Laboratory Evaluation
Obtain the following panel to confirm FHA and exclude other causes 1:
- β-hCG (rule out pregnancy first)
- TSH and free T4 (thyroid dysfunction)
- Prolactin (hyperprolactinemia)
- LH, FSH, estradiol (pattern diagnosis)
- Total testosterone and DHEA-S (if clinical hyperandrogenism present)
- Complete metabolic panel (electrolytes, glucose, liver function—especially if energy restriction suspected)
Critical diagnostic point: In FHA, the LH/FSH ratio may be elevated if underlying PCOS coexists, which can confuse clinicians. The preserved acute gonadotropin response to GnRH stimulation (2-3 fold rise) differentiates FHA from organic hypogonadotropic hypogonadism, though this test is rarely needed clinically 1.
Identify the Underlying Cause
FHA results from three main stressors that create energy deficit 1:
- Excessive exercise or athletic training
- Weight loss/underweight (low BMI)
- Psychological stress (chronic psychosocial stressors)
History must specifically assess: eating patterns, exercise duration/intensity, recent weight changes, BMI trends, psychological stressors, and perfectionist tendencies.
Management Algorithm
First-Line Treatment: Correct Energy Imbalance
The Endocrine Society strongly recommends correcting the energy imbalance as primary therapy 1. This requires:
- Increased caloric consumption and improved nutrition
- Decreased exercise activity (reduce intensity and duration)
- Weight gain when indicated (often necessary)
- Cognitive behavioral therapy (CBT) for psychological support 1
Give this approach 6 months before considering hormonal intervention 1.
What NOT to Do
Avoid oral contraceptive pills (OCPs) for the sole purpose of regaining menses or improving bone mineral density 1. Critical pitfalls:
- OCPs mask the return of spontaneous menses
- Bone loss may continue despite OCPs if energy deficit persists
- This gives false reassurance while the underlying problem worsens
If Menses Don't Return After 6 Months
Only after a reasonable trial of behavioral intervention, consider short-term transdermal estradiol with cyclic oral progestin (not OCPs or ethinyl estradiol) 1. This addresses:
- Bone health concerns (measure BMD by DXA if amenorrhea ≥6 months)
- Hypoestrogenic symptoms
- Endometrial protection
Avoid bisphosphonates, denosumab, testosterone, and leptin for bone density improvement 1.
For Patients Desiring Pregnancy
After complete fertility workup, the treatment hierarchy is 1:
- Pulsatile GnRH (first-line, but unavailable in the United States)
- Gonadotropin therapy (requires cautious use; risk of ovarian hyperstimulation and multiple pregnancy)
- Clomiphene citrate (only if sufficient endogenous estrogen present—unlikely in severe FHA)
- CBT trial (may restore ovulatory cycles without medical intervention)
Important: Women with FHA may require both FSH and LH activity for optimal gonadotropin response. Recombinant FSH alone may be inadequate 1.
Critical Clinical Considerations
When to Hospitalize
Evaluate for inpatient treatment if severe bradycardia, hypotension, orthostasis, or electrolyte imbalance present 1. These indicate dangerous energy deficit requiring immediate intervention.
Rule Out Organic Causes
If FSH and LH are very low or undetectable (not just normal), consider:
- Genetic mutations affecting GnRH (congenital hypogonadotropic hypogonadism)
- Pituitary/hypothalamic tumors
- Infiltrative lesions
- Brain MRI indicated 1
Overlapping PCOS
Some patients have underlying PCOS with superimposed FHA. Monitor closely for hyperresponse if using gonadotropins for fertility treatment 1.
Long-Term Monitoring
The pattern of hormone levels matters more than absolute values 1. Serial measurements help track recovery. Persistently low estradiol (<20 pg/mL) indicates severe hypothalamic suppression requiring more aggressive behavioral intervention.
Address lifetime consequences: bone health (osteoporosis risk), cardiovascular health, and fertility preservation through early, aggressive treatment of the underlying energy deficit.